Pfizer standalone net profit rises 6.30% in the September 2024 quarter
Sales rise 2.33% to Rs 588.59 crore
Net profit of Pfizer rose 6.30% to Rs 158.35 crore in the quarter ended September 2024 as against Rs 148.96 crore during the previous quarter ended September 2023. Sales rose 2.33% to Rs 588.59 crore in the quarter ended September 2024 as against Rs 575.21 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var.Sales588.59575.21 2 OPM %32.1531.75 -PBDT230.22215.95 7 PBT215.23200.52 7 NP158.35148.96 6Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Oct 29 2024 | 7:32 AM IST